维普中文期刊产品整合服务
86篇 您的检索式:作者名="ASHLEY F"
    题名 作者 年代 出处 被引量
1重组脊髓灰质炎病毒用于治疗复发胶质母细胞瘤(英文)显示文摘Background The prognosis of patients with recurrent World Health Organization(WHO)grade IV malignant glioma is dismal,and there is currently no effective therapy.We conducted a dose-finding and toxicity study in this population of patients,evaluating convection-enhanced,intratumoral delivery of the recombinant nonpathogenic polio-rhinovirus chimera(PVSRIPO).PVSRIPO recognizes the poliovirus receptor CD155,which is widely expressed in neoplastic cells of solid tumors and in major components of the tumor microenvironment.Methods We enrolled consecutive adult patients who had recurrent supratentorial WHO grade IV malignant glioma,confirmed on histopathological testing,with measurable disease(contrast-enhancing tumor of≥1 cm and≤5.5 cm in the greatest dimension).The study evaluated seven doses,ranging between 107 and 1010 50%tissue-culture infectious doses(TCID50),first in a dose-escalation phase and then in a dose-expansion phase.Results From May 2012 through May 2017,a total of 61 patients were enrolled and received a dose of PVSRIPO.Dose level-1(5.0×107TCID50)was identified as the phase 2 dose.One dose-limiting toxic effect was observed;a patient in whom dose level 5(1010TCID50)was administered had a grade 4 intracranial hemorrhage immediately after the catheter was removed.To mitigate locoregional inflammation of the infused tumor with prolonged glucocorticoid use,dose level 5 was deescalated to reach the phase 2 dose.In the dose-expansion phase,19%of the patients had a PVSRIPO-related adverse event of grade 3 or higher.Overall survival among the patients who received PVSRIPO reached a plateau of 21%(95%confidence interval,11 to 33)at 24 months that was sustained at 36 months.Conclusions Intratumoral infusion of PVSRIPO in patients with recurrent WHO grade IV malignant glioma confirmed the absence of neurovirulent potential.The survival rate among patients who receivedPVSRIPO immunotherapy was higher at 24 and 36 months than the rate among historical controls.Desjardins A Gromeier M Herndon JE 2nd Beaubier N Bolognesi DP Friedman AH Friedman HS McSherry F Muscat AM Nair S Peters KB Randazzo D Sampson JH Vlahovic G Harrison WT McLendon RE Ashley D Bigner DD 2018中华神经外科疾病研究杂志2018,17,4:2
2Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline显示文摘Philip E. Cryer Lloyd Axelrod Ashley B. Grossman Simon R. Heller Victor M. Montori Elizabeth R. Seaquist F John Service 2009The Journal of Clinical Endocrinology & Metabolism2009,,3:2
3The effects of ω3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial显示文摘Trevor A Mori Valerie Burke Ian B Puddey Ashley B Irish Christine A Cowpland Lawrence J Beilin Gursharan K Dogra Gerald F Watts 2009Journal of Hypertension2009,,9:1
4Discrimination of hydrothermally altered rocks and unaltered rocks in visible and near infrared multi- spectral images显示文摘ROWAN L C GOETZ A F H ASHLEY R P 1977Geophysics1977,42,3:1
5Improving the safety of chemo- therapy administration:An oncology nurse failure mode and effects a- nalysis显示文摘Ashley L Dexter R Marshall F 2011Oncol Nurs For2011,38,6:1
6On Radar Detection and Direction Finding using Sparse Arrays显示文摘Ashley F Engdahl C Sunnergren P IEEE Transactions on Aerospace and Electronic Systems0,43,4:1
7Prognostic value of heart rate incrase at onset of exercise testing显示文摘Leeper N J Dewey F E Ashley E A 2007Circulation2007,115,4:1
8Overexpression of AtCpNifS enhances selenium tolerance and accumulation in Arabidopsis显示文摘Douglas V H Gulnara F G Ashley R A 2005Plant Physiol2005,139,:1
9Stereotactic radiotherapy ( SABR )for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort显示文摘Sold t F Lodge M Ashley S 2013Radiother Oncol2013,109,1:1
10Bacterial endophytes: recent developments and applications显示文摘Robert P R Kieran G Ashley F 2008FEMS Microbiol Letters2008,278,1:1
11Discrimination of hydrothermally altered and unaltered rocks in visible and near infrared multispectral images显示文摘Rowan L C Goetz A F H Ashley R P 1977Geophysics1977,42,:1
12Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual显示文摘S.Eva Singletary Craig Allred Pandora Ashley Lawrence W Bassett Donald Berry Kirby I Bland Patrick I Borgen Gary M Clark Stephen B Edge Daniel F Hayes Lorie L Hughes Robert V.P Hutter Monica Morrow David L Page Abram Recht Richard L Theriault Ann Thor Don 2003Surgical Clinics of North America2003,,4:1
13Discrimination of hydro thermally altered and unaltered rocks in visible and near infrared multi-spectral images 显示文摘ROWAN L C GOETZ A F H ASHLEY P 1977Geophysics1977,,42:1
14A Gis-supported model for the simulation of the spatial structure of wild land fire,Cass Basin显示文摘George L M Perry Ashley D Sparrow Lan F Owens 1999Journal of Applied Ecology1999,,36:1
15Face-lift complications: a study of 922 cases performed in a 6-year period显示文摘THOMPSON D P ASHLEY F L 1978Plast Recon- str Surg1978,61,1:1
16Natural gas conversion to liquid fuels in a zone reactor显示文摘Ashley Breed Michael F Doherty Sagar Gadewar 2005Catalysis Today2005,106,1234:1
17Improving the safety of chemotherapy administration: an oncology nurse- led fail- ure mode and effects analysis显示文摘Ashley L Dexter R Marshall F 2011Oncol Nuts Forum2011,38,6:1
18Crossing Extreme Mechanistic Barriers By Antibody Catalysis:Syn Elimination to a Cis Olefin显示文摘Cravatt B F Ashley J A Janda K D 1994J Am Chem Soc1994,116,13:1
19Expres- sion of interferon (IFN)-stimulated genes in extrau- terine tissues during early pregnancy in sheep is the consequence of endocrine IFN-tau release from the uterine vein 显示文摘Oliveira J F Henkes L E Ashley R L 2008Endocrinol2008,149,3:1
20Antenna-coupled microbolometer arrays with aerogel thermal isolation 显示文摘Gonzalez F J Ashley C S Clem P G 2004Infrared Physics & Technology2004,45,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费